Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Important Update on FDA Changes Concerning Peptides of the Federal Food, Drug, and Cosmetic Act (FDCA).* CJC 1295 + Ipamorelin: Benefits, Differences, and When to Combine Revolution Health & Wellness